Bottom line
Is SAGP a good fund? The bottom line
SAGP is a managed global stock ETF from SEI.
Its expense ratio is 0.65% — about $65 a year on every $10,000 invested, cheaper than 82% of global stock funds we track.
It returned +22.6% over one year (as of Dec 31, 2025, per its prospectus).
With $76.6 million in net assets and 100 holdings, its largest position is Teradyne, Inc. (2.6%) and the top 10 make up 21.7% of the portfolio.
What stands out
- Low cost: cheaper than 82% of global stock peers
Updated Nov 19, 2026
What SAGP invests in
The Strategas Global Policy Opportunities ETF (the Global Policy Opportunities ETF or the Fund) seeks long-term capital appreciation.
The Fund is an actively-managed exchange-traded fund (ETF) that seeks to achieve its objective by investing principally in the common stocks of U.S. and non-U.S. companies interested in influencing public policy through their lobbying activity in Washington D.C. Strategas Asset Management, LLC (the Adviser) considers lobbying a nontraditional and largely unrecognized factor in company analysis. By utilizing publicly available lobbying data in its portfolio selection methodology, the Adviser seeks to capitalize on what the Adviser perceives as a lack of consideration given to lobbying in traditional financial analysis and lobbyings potential to sway policy outcomes in companies favor. The Adviser believes that successful lobbying activity can reduce costly regulatory and legislative harm to a company, impose such harm onto competitors, and/or result in beneficial legislative and…
From the fund's prospectus (filed Apr 30, 2026).
SAGP performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| SAGP | +22.6% | — | — |
| Global Stock median | +15.2% | +7.6% | +9.5% |
Source: Fund prospectus, as of Dec 31, 2025
What SAGP costs
On a $10,000 investment, SAGP's 0.65% expense ratio costs about $65 a year. The prospectus estimates $810 in total costs over 10 years (assuming 5% annual returns). The median global stock fund charges 0.95%.
SAGP top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Teradyne, Inc. | 2.61% |
| 2 | Axon Enterprise, Inc. | 2.34% |
| 3 | Stanley Black & Decker, Inc. | 2.27% |
| 4 | Ciena Corporation | 2.11% |
| 5 | Davita Inc. | 2.10% |
| 6 | Chipotle Mexican Grill, Inc. | 2.09% |
| 7 | Biogen Inc. | 2.08% |
| 8 | A. O. Smith Corporation | 2.05% |
| 9 | Humana Inc. | 2.04% |
| 10 | Incyte Corporation | 2.01% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 21.7% of the fund. See all top 25 holdings and asset mix →